Document:

Registration Rights Agreement dated December 1, 2005

 Exhibit 10.ii.b. 
  
  
  
 REGISTRATION RIGHTS AGREEMENT 
  
 This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of December 1, 2005 by and between The Mosaic Company, a Delaware corporation (the “Company”), and U.S. Agri-Chemicals
Corporation, a Florida corporation (“USAC”). 
  
 RECITALS 
  
 WHEREAS, the Company, Mosaic
Fertilizer, LLC, a Delaware limited liability company and a subsidiary of the Company (“Mosaic Fertilizer”), USAC and Sinochem Corporation, a corporation organized under the laws of the People’s Republic of China, have entered
into an Asset Purchase Agreement dated October 13, 2005 (the “Purchase Agreement”) providing for, among other things, (i) the sale to Mosaic Fertilizer by USAC of certain equipment, spare parts and certain other tangible
assets of USAC (the “Phosphate Assets”) and the S-1 Property (as defined in the Purchase Agreement) and (ii) in consideration therefor, the issuance by the Company to USAC of a number of shares (the “Shares”)
of common stock, $0.01 par value per share, of the Company (the “Common Stock”) obtained by dividing the Phosphate Asset Purchase Price and the S-1 Purchase Price (each as defined in the Purchase Agreement) by $13.17; 
  
 WHEREAS, the parties hereto hereby desire to set forth the rights of
the holders of the Registrable Securities (as hereinafter defined) to, and the Company’s obligations to, cause the registration of the resale of the Registrable Securities pursuant to the Securities Act (as hereinafter defined); 
  
 WHEREAS, Section 7.1(h) of the Purchase Agreement provides that,
as a condition to USAC’s obligations to effect the sale of the Assets and the other transactions contemplated by the Purchase Agreement, USAC and the Company shall have executed and delivered this Agreement and this Agreement shall remain in
full force and effect; and 
  
 WHEREAS, USAC acknowledges
that the Company has entered into a Registration Rights Agreement dated January 26, 2004 (the “Cargill Registration Rights Agreement”) with Cargill, Incorporated (“Cargill”) pursuant to which Cargill and/or
certain other holders of the Company’s securities, under certain circumstances, may have registration rights with respect to shares of Common Stock that are superior to the rights granted hereunder. 
  
 NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
  
 1. Definitions. Unless otherwise provided in this Agreement,
capitalized terms used herein shall have the following meanings: 

 “Agreement” has the meaning set forth in the first paragraph above. 
  
 “Cargill” has the meaning set forth in the Recitals.

  
 “Cargill Registration Rights Agreement” has
the meaning set forth in the Recitals. 
  
 “Closing
Date” means the “Phosphate Closing Date” as defined in Section 2.5 of the Purchase Agreement. 
  
 “Commission” means the Securities and Exchange Commission. 
  
 “Common Stock” has the meaning set forth in the Recitals. 
  
 “Company” has the meaning set forth in the first paragraph
above. 
  
 “Demand Registration” has the meaning
set forth in Section 3.1. 
  
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended. 
  
 “Final Prospectus” has the meaning set forth in Section 8.1. 
  
 “Person” means any individual, corporation, association, limited liability company, partnership, trust or estate, unincorporated
organization, joint venture, a government or any agency or political subdivision thereof, or any other entity of whatever nature. 
  
 “Piggyback Registration” has the meaning set forth in Section 4.1. 
  
 “Purchase Agreement” has the meaning set forth in the
Recitals. 
  
 “Qualified Holders” means the
holders of a majority of the Registrable Securities then outstanding. 
  
 “Registrable Securities” means (a) the Shares, (b) any shares of Common Stock issued or issuable with respect to the Shares by way of a stock dividend or stock split or in connection with a combination of shares,
recapitalization, merger, consolidation or other reorganization and (c) all shares of Common Stock issued or issuable to a holder of the Shares in respect of any shares of Common Stock acquired by the holder pursuant to any of the transactions
described in the preceding clause (b). As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when (i) they have been distributed to the public pursuant to an offering registered under the
Securities Act, (ii) they have been sold to the public through a broker, dealer or market maker in compliance with Rule 144 under the Securities Act (or any similar rule then in force) or (iii) at the time of any Demand Registration
or Piggyback Registration they, together with all other Registrable Securities held by the holder thereof, have satisfied the two-year holding period required by paragraph (k) of Rule 144 under the Securities Act and are legally permitted
to be publicly sold without registration with the SEC pursuant to paragraph (k) of Rule 144. 
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  

 -2- 

 “Shares” has the meaning set forth in the Recitals. 
  
 “Shelf Registration” has the meaning set forth in
Section 3.2. 
  
 “Suspension Period”
has the meaning set forth in Section 6.2. 
  
 “USAC” has the meaning set forth in the first paragraph above. 
  
 “Violation” has the meaning set forth in Section 8.1. 
  
 2. Restriction on Transfer. Until the 18-month anniversary of the Closing Date, USAC will not sell, transfer or otherwise dispose of,
directly or indirectly, any of the Shares to any Person who is not an Affiliate of USAC (a “Third Person”), unless such transaction is approved in advance by the Company in its sole discretion. Any sale, transfer or other
disposition made in violation of this Section 2 shall be null and void, and the Company shall not register any such sale, transfer or other disposition in its books and records. Upon original issuance of the Shares, each certificate
representing the Shares shall include a legend in substantially the following form: 
  

	
	“The securities represented by this certificate may only be transferred pursuant to the provisions of a Registration Rights Agreement, dated as of December 1, 2005, as amended from
time to time, between the issuer and U.S. Agri-Chemicals Corporation, copies of which are on file at the principal office of the issuer”

  
 Each certificate representing the
Shares issued to USAC or to any subsequent holder of such shares shall also include a legend in substantially the following form; provided, however, that such legend shall not be required if (i) a transfer is being made in
connection with a sale of the Shares registered under the Securities Act or in connection with Rule 144 under the Securities Act, or (ii) upon receipt by the Company of an opinion of counsel to the effect that such legend is not required
in order to ensure compliance with the Securities Act: 
  

	
	“The securities represented by this certificate have not been registered under the federal Securities Act of 1933, as amended, or applicable state securities laws and may not be sold,
transferred, offered or otherwise disposed of in the absence of an effective registration statement under applicable securities laws or an opinion of counsel reasonably satisfactory to The Mosaic Company that such registration is not
required.”

  
 3. Demand
Registration. 
  
  
 3.1 Requests for Registration. At any time beginning 30 days prior to the 18-month anniversary of the Closing Date, the Qualified Holders may,
subject to Section 3.2, request registration under the Securities Act of all or any portion of their Registrable Securities on Form S-3 or any similar short-form registration statement (a “Demand Registration”),
provided that no such Demand Registration shall be required to become effective before the 18-month anniversary of the Closing Date. If for any reason the Company is not eligible to file a 

  

 -3- 

 
Demand Registration on Form S-3 or any similar short-form registration statement, then the Company shall effect such Demand Registration using such form as
the Company is then eligible to use. The request for a Demand Registration shall specify the approximate number of Registrable Securities requested to be registered and the intended method of distribution. Within ten days after receipt of such
request, the Company shall give written notice of such requested registration to all other holders of Registrable Securities and, subject to Section 3.3, shall include as part of such Demand Registration all Registrable Securities with
respect to which the Company has received written requests for inclusion therein within 15 days after the receipt of the Company’s notice by such holders. 
  

3.2 Limitations on Demand Registration. The holders of the Registrable Securities shall be entitled to request one (1) Demand Registration
with respect to Registrable Securities; provided, that, the aggregate offering price of Registrable Securities requested to be registered in such Demand Registration must be equal to at least $10 million. The holders of a majority of
the Registrable Securities which are included in a Demand Registration may require the Company to file such Demand Registration with the Commission in accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor
rule then in effect) (a “Shelf Registration”). 
  
 3.3 Priority on Demand Registration. If a Demand Registration is an underwritten offering and the managing underwriters advise the Company in writing, with a copy to be delivered to all the holders of Registrable Securities, that, in
their opinion, the number of Registrable Securities requested to be included in such offering exceeds the number of securities which can be sold therein without materially adversely affecting the marketability of the offering and within a price
range acceptable to the holders of a majority of the Registrable Securities requesting registration, the Company shall first include in such registration, prior to the inclusion of any securities which are not Registrable Securities, the Registrable
Securities requested to be included which in the opinion of such underwriters can be sold without materially adversely affecting the marketability of the offering, pro rata among the respective holders thereof on the basis of the amount of
Registrable Securities owned by each such requesting holder. 
  
 3.4 Restrictions on Registration. The Company shall not be obligated to effect a Demand Registration within 270 days after the effective date of a registration of Common Stock in which the holders of Registrable Securities were given
piggyback rights pursuant to Section 4 and in which there was no reduction in the number of Registrable Securities requested to be included. The Company may postpone for up to 90 days the filing or the effectiveness of a registration
statement for a Demand Registration if the Company furnishes to the Qualified Holders a certificate signed by the Chief Financial Officer of the Company stating that such Demand Registration would reasonably be expected to have a material adverse
effect on any proposal or plan by the Company or any of its subsidiaries to engage in any financing, acquisition of assets (other than in the ordinary course of business) or any merger, consolidation, tender offer, reorganization or other
significant transaction; provided, that, in such event, the holders of Registrable Securities initially requesting such Demand Registration shall be entitled to withdraw such request and, if such request is withdrawn, such Demand
Registration shall not count as the permitted Demand Registration hereunder; and provided, further, that the Company may not exercise this deferral right more than once in any 12-month period. 
  

 -4- 

 3.5 Selection of Underwriters. The Company shall have the right to select the investment banker(s)
and manager(s) to administer the offering in connection with a Demand Registration, subject to the approval of the holders of a majority of the Registrable Securities included in such Demand Registration (which approval shall not be unreasonably
withheld or delayed). 
  
 4. Piggyback Registrations.

  
 4.1 Right to Piggyback. At any time beginning 30
days prior to the 18-month anniversary of the Closing Date, whenever the Company proposes to register any of its securities under the Securities Act (other than pursuant to a Demand Registration which shall be governed by Section 3, and
registrations related solely to employee benefit plans or a Rule 145 transaction) and both (i) the registration form to be used may be used for the registration of Registrable Securities, and (ii) the registration is reasonably
expected to become effective after the 18-month anniversary of the Closing Date (a “Piggyback Registration”), the Company shall give prompt written notice to all holders of Registrable Securities of its intention to effect such a
registration and, subject to the terms hereof, shall include in such registration all Registrable Securities with respect to which the Company has received written requests for inclusion therein within 21 days after such holders receive the
Company’s notice. 
  
 4.2 Priority on Primary
Registrations. If a Piggyback Registration is an underwritten primary registration on behalf of the Company, and the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in
such registration exceeds the number which can be sold therein without adversely affecting the marketability of the offering, the Company shall include in such registration (a) first, the securities the Company proposes to sell,
(b) second, any securities Cargill proposes to sell pursuant to the Cargill Registration Rights Agreement, (c) third, the Registrable Securities requested to be included in such registration, pro rata among the respective holders
thereof on the basis of the amount of Registrable Securities owned by each such holder and (d) fourth, other securities requested to be included in such registration. 
  
 4.3 Priority on Other Registrations. If a Piggyback Registration is an underwritten secondary registration on behalf
of holders of the Company’s securities other than holders of Registrable Securities, and the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in such registration
exceeds the number which can be sold in such offering without adversely affecting the marketability of the offering, the Company shall include in such registration (a) first, the securities requested to be included therein by the holders
requesting such registration, (b) second, any securities Cargill proposes to sell pursuant to the Cargill Registration Rights Agreement, (c) third, the Registrable Securities requested to be included in such registration, pro rata
among the holders of such securities on the basis of the number of Registrable Securities owned by each such holder and (d) fourth, other securities requested to be included in such registration. 
  
 4.4 Selection of Underwriters. The Company shall have the right to
select the investment banker(s) and manager(s) to administer the offering in connection with any Piggyback Registration. 
  

 -5- 

 5. Holdback Agreements. Each holder of Registrable Securities shall not effect any public
sale or distribution (including sales pursuant to Rule 144) of equity securities of the Company, or any securities convertible into or exchangeable or exercisable for such securities, or engage in any hedging transactions relating to the same,
during the 30 days prior to and the 90-day period beginning on the effective date of any underwritten Demand Registration or any underwritten Piggyback Registration, in each case pursuant to which such holder’s Registrable Securities are
included (except as part of such underwritten registration), unless the underwriters managing the registered public offering agree otherwise. 
  
 6. Registration Procedures. Whenever the holders of Registrable Securities have requested that any Registrable Securities be registered
pursuant to this Agreement, the Company shall use commercially reasonable efforts to effect the registration and the sale of such Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto the Company
shall as expeditiously as possible: 
  
 6.1    prepare and file with the Commission a registration statement and such amendments and supplements as may be necessary with respect to such Registrable Securities and use its commercially reasonable efforts to
cause such registration statement to become effective; 
  
 6.2    notify each holder of Registrable Securities of the effectiveness of each registration statement filed hereunder and prepare and file with the Commission such amendments and supplements to such registration
statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period of not less than 120 days (or until the distribution described in the registration statement has been completed)
(or, in the case of a Shelf Registration, a period ending on the earlier of (i) the date on which all Registrable Securities have been sold pursuant to the Shelf Registration or have otherwise ceased to be Registrable Securities, and
(ii) the 24-month anniversary of the effective date of such Shelf Registration) and comply with the provisions of the Securities Act with respect to the disposition of securities covered by such registration statement during such period in
accordance with the intended methods of disposition by the sellers thereof set forth in such registration statement; provided, however, that at any time, upon written notice to the participating holders of Registrable Securities and
for a period not to exceed forty-five (45) days thereafter (the “Suspension Period”), the Company may suspend the use or effectiveness of any registration statement (and the holders of Registrable Securities participating in
such offering hereby agree not to offer or sell any Registrable Securities pursuant to such registration statement during the Suspension Period) if the Company reasonably believes that the Company may, in the absence of such suspension hereunder, be
required under state or federal securities laws to disclose any corporate development the disclosure of which could reasonably be expected to have a material adverse effect upon the Company, its stockholders, a potentially significant transaction or
event involving the Company, or any negotiations, discussions, or proposals directly relating thereto. No more than two (2) such Suspension Periods shall occur in any twelve (12) month period. In the event that the Company shall exercise
its rights hereunder, the applicable time period during which the registration statement is to remain effective shall be extended by a period of time equal to the duration of the Suspension Period. The Company may extend the Suspension Period for an
additional consecutive thirty (30) days with the consent of the holders of at least a majority of the Registrable Securities proposed to be sold by the holders 

  

 -6- 

 
participating in such offering. If so directed by the Company, the holders of Registrable Securities shall use their commercially reasonable efforts to
deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such holders’ possession, of the prospectus relating to such Registrable Securities current at the time of receipt of such notice;

  
 6.3    furnish to each seller of
Registrable Securities such number of copies of such registration statement, each amendment and supplement thereto, the prospectus included in such registration statement (including each preliminary prospectus) and such other documents as such
seller may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such seller; 
  
 6.4    use commercially reasonable efforts to register or qualify such Registrable Securities under such other securities or blue sky
laws of such jurisdictions and do any and all other acts and things which may be reasonably necessary or advisable to enable such seller to consummate the disposition in such jurisdictions of the Registrable Securities owned by such seller
(provided, however, that the Company shall not be required to (a) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this subsection, (b) subject itself to
taxation in any such jurisdiction or (c) consent to general service of process in any such jurisdiction); 
  
 6.5    promptly notify each seller of such Registrable Securities, at any time when a prospectus relating thereto is required to be
delivered under the Securities Act, of the happening of any event as a result of which the prospectus included in such registration statement contains an untrue statement of a material fact or omits any fact necessary to make the statements therein
not misleading, and, at the request of any such seller, the Company shall prepare a reasonable number of copies of a supplement or amendment to such prospectus so that, as thereafter delivered to the sellers of such Registrable Securities, such
prospectus shall not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading, in which event the period mentioned in Section 6.2 shall be extended by the length of the
period from and including the date when each seller of such Registrable Securities shall have received such notice to the date on which each such seller has received the copies of the supplemented or amended prospectus contemplated under this
Section 6.5; 
  
 6.6    cause all such
Registrable Securities to be listed on each securities exchange and/or quotation system on which similar securities issued by the Company are then listed and/or quoted; 
  
 6.7    provide a transfer agent and registrar for all such Registrable Securities not later than the
effective date of such registration statement; 
  
 6.8    enter into such customary agreements (including underwriting agreements in customary form) and take all such other actions as the underwriters, if any, reasonably request in order to expedite or facilitate the
disposition of such Registrable Securities; 
  

 -7- 

 6.9    make available for inspection by any seller of Registrable Securities, any
underwriter participating in any disposition pursuant to such registration statement, and any attorney, accountant or other agent retained by any such seller or underwriter, all financial and other records, pertinent corporate documents and
properties of the Company, and cause the Company’s officers, directors, employees and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection with such
registration statement; 
  
 6.10    otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
months beginning with the first day of the Company’s first full calendar quarter after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and
Rule 158 thereunder; 
  
 6.11    in the
event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending or preventing the use of any related prospectus or suspending the qualification of any Common Stock included in such
registration statement for sale in any jurisdiction, the Company shall use its commercially reasonable efforts promptly to obtain the withdrawal of such order; and 
  
 6.12    use its commercially reasonable efforts to cause such Registrable Securities covered by such
registration statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate the disposition of such Registrable Securities. 
  
 The holders of the Registrable Securities agree to comply with any prospectus
delivery and/or notice requirements under the Securities Act then in effect, and agree to not use any “free-writing” prospectus in connection with the sale of any Registrable Securities. 
  
 7. Registration Expenses. All expenses incident to the
Company’s performance of or compliance with this Agreement (whether with respect to a Demand Registration or Piggyback Registration), including, without limitation, all registration and filing fees, fees of any transfer agent and registrar,
fees and expenses of compliance with securities or blue sky laws, printing expenses, fees and disbursements of counsel for the Company, fees and disbursements of one counsel chosen by the holders of a majority of the Registrable Securities included
in such registration, fees and expenses of the Company’s independent certified public accountants, fees and expenses of underwriters (but specifically excluding underwriters fees, discounts, commissions and similar payments attributable to the
Registrable Securities included in such registration), the Company’s internal expenses and the expenses and fees for listing the securities to be registered on each securities exchange or quotation system on which similar securities issued by
the Company are then listed or quoted, shall be borne by the Company. 
  
 8. Indemnification. 
  
 8.1 In connection
with any Demand Registration or Piggyback Registration, the Company agrees to indemnify, to the extent permitted by law, each holder of Registrable 

  

 -8- 

 
Securities, the partners or officers, directors and equity holders of such holder, and each Person who controls such holder (within the meaning of the
Securities Act) against all losses, claims, damages, liabilities (joint or several) and expenses incurred by such party arising out of, based upon or caused by any of the following statements, omissions or violations (each, a
“Violation”): (i) any untrue or alleged untrue statement of material fact contained in any registration statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto, (ii) any omission or
alleged omission of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or (iii) any violation or alleged violation by the Company of
the Securities Act, the Exchange Act, any state securities laws or any rule or regulation promulgated under the Securities Act, Exchange Act or any state securities laws; and the Company will reimburse each such holder, each of its partners,
officers, directors and equity holders, and each Person controlling such holder for any legal or other expenses reasonably incurred, as such expenses are incurred, by any of them in connection with investigating or defending any such loss, claim,
damage, liability or action; provided, however, that the Company shall not be liable in any such case for any such loss, claim, damage, liability or action (x) to the extent that it is caused by a Violation that occurs in reliance
upon and in conformity with any information furnished in writing to the Company by such holder, and stated to be specifically for use in such registration, or (y) insofar as it relates to any untrue or alleged untrue statement of material fact,
or any omission or alleged omission of a material fact required to be stated in the registration statement or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, made in a preliminary
prospectus on file with the Commission at the time the registration statement becomes effective or the amended prospectus is filed with the Commission pursuant to Rule 424(b) (the “Final Prospectus”), if a copy of the Final
Prospectus was not furnished to the Person asserting the loss, liability, claim or damage at or prior to the time such action is required by the Securities Act, and if the Final Prospectus would have cured the defect giving rise to the loss,
liability, claim or damage. 
  
 8.2 In connection with any Demand
Registration or Piggyback Registration in which a holder of Registrable Securities is participating, each such holder agrees to indemnify, to the extent permitted by law, the Company, its directors, officers, any other holder selling securities in
such Demand Registration or Piggyback Registration, and each Person who controls the Company (within the meaning of the Securities Act) against all losses, claims, damages, liabilities (joint or several) and expenses arising out of, based upon or
caused by any Violation, but only (i) to the extent that such Violation is caused by any information furnished in writing by such holder, and stated to be specifically for use in such registration, or (ii) insofar as they relate to
any untrue or alleged untrue statement of material fact, or any omission or alleged omission of a material fact required to be stated in the registration statement or necessary to make the statements therein, in light of the circumstances in which
they were made, not misleading, made in a preliminary prospectus on file with the Commission at the time the registration statement becomes effective or the Final Prospectus is filed with the Commission, if a copy of the Final Prospectus was not
furnished to the Person asserting the loss, liability, claim or damage at or prior to the time such action is required by the Securities Act, and if the Final Prospectus would have cured the defect giving rise to such loss, liability, claim or
damage; and such holder will reimburse the Company and each such Person for any legal or other expenses reasonably incurred, as such expenses are incurred, by any of them in connection with investigating or defending any such loss, claim, damage,
liability or expense; provided, that, the obligation to 

  

 -9- 

 
indemnify shall be individual, not joint and several, for each holder and shall be limited to the net amount of proceeds received by such holder from the
sale of Registrable Securities pursuant to such registration statement. 
  
 8.3 Any Person entitled to indemnification hereunder shall (a) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not
impair any Person’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party’s ability to defend such claim), and (b) unless in the written opinion of legal counsel to such indemnified or
indemnifying parties a conflict of interest between such indemnified and indemnifying parties exists with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the
indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying
party who is not entitled to, or elects not to, assume the defense of a claim shall be obligated to pay the fees and expenses of one counsel (but not more than one) for all parties indemnified by such indemnifying party with respect to such claim,
unless in the reasonable judgment (with written advice of counsel) of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. 
  
 8.4 The indemnification provided for under this Agreement shall remain in
full force and effect regardless of any investigation made by or on behalf of the indemnified party or any partner, officer, director or controlling Person of such indemnified party and shall survive the transfer of securities. Each party also
agrees to make such provisions, as are reasonably requested by the other party, for contribution in the event the indemnification provided for in this Agreement is unavailable for any reason. 
  
 9. Participation in Underwritten Registrations. No
Person may participate in any registration hereunder which is underwritten unless such Person (a) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by the Company and (b) completes
and executes all questionnaires, powers of attorney and other documents reasonably required under the terms of such underwriting arrangements; provided, that, no holder of Registrable Securities included in any underwritten
registration shall be required to make any representations or warranties to the Company or the underwriters (other than representations and warranties regarding such holder and such holder’s intended method of distribution) or to undertake any
indemnification obligations to the Company or the underwriters with respect thereto, except to the extent of the indemnification provided in Section 8. 
  
 10. Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations
of the Commission which may at any time permit the sale of any Registrable Securities to the public without registration after the 18-month anniversary of the Closing Date, the Company agrees to use commercially reasonable efforts to: 
  
 10.1 File, as and when applicable, with the Commission in a timely manner all
reports and other documents required of the Company under the Exchange Act; and 
  

 -10- 

 10.2 After the 18-month anniversary of the Closing Date, if the Company is not required to file reports
pursuant to the Exchange Act, upon the request of any holder of Registrable Securities, the Company shall make publicly available the information specified in subparagraph (c)(2) of Rule 144 of the Securities Act. 
  
 11. Miscellaneous. 
  
 11.1 Effective Date. This Agreement shall not be effective (and the
parties hereto shall not be bound by any obligations hereunder) until the Closing Date. In the event that the Purchase Agreement is terminated without consummation of the transactions contemplated therein, this Agreement shall automatically
terminate without any action on the part of either party to this Agreement and neither party hereto shall have any liability or obligation to the other party under this Agreement. 
  
 11.2 No Inconsistent Agreements. The Company shall not hereafter enter into any agreement with respect to its
securities which is inconsistent with or violates the rights granted to the holders of Registrable Securities in this Agreement. 
  
 11.3 Remedies. Any Person having rights under any provision of this Agreement shall be entitled to enforce such rights specifically to recover
damages caused by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. The parties hereto agree and acknowledge that money damages are not an adequate remedy for any breach of the provisions of
this Agreement and that any party may apply for specific performance and for other injunctive relief in order to enforce or prevent violation of the provisions of this Agreement. 
  
 11.4 Amendments and Waivers. Except as otherwise provided herein, the provisions of this Agreement may be amended or
waived only upon the prior written consent of (a) the Company and (b) the holders of a majority of the Registrable Securities then outstanding. 
  
 11.5 Successors, Assigns and Subsequent Holders. 
  
 (a) All covenants and agreements in this Agreement by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective
successors and the permitted assigns of the parties hereto. 
  
 (b) The rights to cause the Company to register Registrable Securities pursuant to this Agreement may not be assigned without the prior written consent of the Company. No assignment or transfer pursuant to this Section 11.5
shall be effective unless and until (i) the Company is furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned and (ii) such
transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement. 
  
 11.6 Entire Agreement. This Agreement and the Purchase Agreement constitute the entire agreement of the parties hereto with respect to the subject
matter contained herein, and supersede and preempt all prior agreements, negotiations, discussions and understandings among the parties hereto with respect to such subject matter. 
  

 -11- 

 11.7 Severability. Wherever possible, each provision of this Agreement will be interpreted in such
manner as to be effective and valid under applicable law and in such a way as to, as closely as possible, achieve the intended economic effect of such provision and this Agreement as a whole, but if any provision contained herein is, for any reason,
held to be invalid, illegal or unenforceable in any respect, such provision shall be ineffective to the extent, but only to the extent, of such invalidity, illegality or unenforceability without invalidating the remainder of such provision or any
other provisions hereof, unless such a construction would be unreasonable. 
  
 11.8 Notices. All notices or other communications required or permitted hereunder shall be in writing and shall be deemed given upon delivery (a) when delivered personally, (b) if transmitted by
facsimile when confirmation of transmission is received, (c) if sent by registered or certified mail, postage prepaid, return receipt requested or (d) if sent by reputable overnight courier service (providing proof of delivery); and shall
be addressed as follows: 
  

			
	 To the Company:
  
 The Mosaic Company
 Atria Corporate Center, E490
 3033 Campus Drive
 Plymouth, Minnesota 55441
 Attention: Richard L. Mack
 Facsimile: (763) 577-2990
	  	 with a copy to:
  
 Dorsey & Whitney LLP
 50 South Sixth Street
 Minneapolis, Minnesota 55402
 Attention: Robert A. Rosenbaum, Esq.
 Facsimile: (612) 340-7800

		
	 To USAC:
  
 USAC Holdings, Inc.
 2701 N. Rocky Pointe Drive
 Suite 1030
 Tampa, Florida 33607
 Attention: Mr. Hongwei Yang, President
 Facsimile:
(813) 289-2954
	  	 with a copy to:
  
 Peterson & Myers, P.A.
 141 5th Street N.W.
 Winter Haven, Florida 33881
 Attention: David Alexander III, Esq.
 Facsimile: (863) 299-5498

  
 11.9 Governing
Law. THE DOMESTIC LAW, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES, OF THE STATE OF DELAWARE WILL GOVERN ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY AND INTERPRETATION OF THIS AGREEMENT AND THE PERFORMANCE OF THE OBLIGATIONS IMPOSED
BY THIS AGREEMENT. 
  
 11.10 Submission to Jurisdiction; Waiver
of Jury Trial. (a) Each of the parties hereby irrevocably submits in any suit, action or proceeding arising out of or related to this Agreement, or any of the transactions contemplated hereby or thereby, to the exclusive jurisdiction of any
state or federal court located in Wilmington, Delaware, and, to the extent permissible by law, waives any and all claims and objections that any such court is an inconvenient forum. 
  

 -12- 

 (b) EACH OF THE PARTIES HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY IN ANY DISPUTE, WHETHER
SOUNDING IN CONTRACT, TORT OR OTHERWISE, BETWEEN OR AMONG ANY OF THE PARTIES ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY OTHER INSTRUMENT OR DOCUMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH. ANY PARTY MAY
FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. 
  
 11.11 Attorneys’ Fees. Except as otherwise specifically provided herein, in the event of any action or suit
based upon or arising out of any actual or alleged breach by any party of any provision of this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees and expenses of such action or suit from the losing
party, in addition to any other relief ordered by the court. 
  
 11.12 Signatures; Counterparts. This Agreement may be executed in one or more counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts taken together will constitute one and the
same instrument. A facsimile signature will be considered an original signature. 
  
 [Signature page follows] 
  

 -13- 

 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be
executed the day and year first above written. 
  

			
	THE MOSAIC COMPANY
		
	By:	 	 
	 	 	 Name:
 Title:

	  
  
 U.S. AGRI-CHEMICALS CORPORATION

		
	By:	 	 
	 	 	 Name:
 Title:

  
  
  
  
  

 Signature Page 
 to the 
 Registration Rights AgreementEmployment Agreement

 Exhibit 10.1 
  
 EMPLOYMENT AGREEMENT 
  
 THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the 22nd day of December, 2005, by and between Spectrum
Brands, Inc., a Wisconsin corporation (the “Company”) and David R Lumley (the “Executive”). 
  
 WHEREAS, the Company desires to employ the Executive upon the terms and conditions set forth herein; and 
  
 WHEREAS, the Executive is willing and able to accept such employment on such
terms and conditions; and 
  
 WHEREAS, Executive’s initial or
continued employment with the Company is expressly conditioned upon the agreement by the Executive to the terms and conditions of such employment as contained in this Agreement. 
  
 NOW, THEREFORE, in consideration of the promises and mutual agreements contained herein (promises that include benefits to
which Executive would not otherwise be entitled or receive), and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Executive hereby agree as follows: 
  

	1.	Employment Duties and Acceptance. The Company hereby employs the Executive, and the Executive agrees to serve and accept employment with the Company as President, North
America, reporting directly to Chairman & Chief Executive Officer of the Company. During the Term (as defined below) the Executive shall devote all of his working time to such employment and appointment, and shall devote his best efforts to
advancing the interests of the Company. 

  

	2.	Term of Employment. The Executive’s employment and appointment hereunder shall be for a term commencing on the January 16th 2006 and expiring January 15th 2009 (three years from date of commencement) (the “Term”). Upon expiration of the Term, this Agreement shall automatically extend for successive periods of one (1) year, unless the Executive or the Company
shall give notice to the other at least ninety (90) days prior to the end of the Term (or any annual extension thereof) indicating that it does not intend to renew the Agreement. 

  

	3.	Compensation. In consideration of the performance by the Executive of his duties hereunder, the Company shall pay or provide to the Executive the following compensation which
the Executive agrees to accept in full satisfaction for his services, it being understood that necessary withholding taxes, FICA contributions and the like shall be deducted from such compensation: 

  

	 	(a)	Base Salary. The Executive shall receive a base salary of Five Hundred Thousand Dollars ($500,000) per annum effective January 16th 2006 

 for the duration of the Term (“Base Salary”), which Base Salary shall be paid in equal
semi-monthly installments each year, to be paid semi-monthly in arrears. The Board of Directors of the Company (the “Board”) will review from time to time the Base Salary payable to the Executive hereunder and may, in its discretion,
increase the Executive’s Base Salary. Any such increased Base Salary shall be and become the “Base Salary” for purposes of this Agreement. 
  

	 	(b)	Bonus. The Executive shall receive a bonus for each fiscal year ending during the Term, payable annually in arrears, which shall be based on Seventy-Five percent
(75%) of Base Salary paid during such fiscal year, provided the Company achieves certain annual performance goals established by the Board from time to time (the “Bonus”). The Board may, in its discretion, increase the annual Bonus.
Any such increased annual Bonus shall be and become the “Bonus” for such fiscal year for purposes of this Agreement. For Financial year 2006, calculation of earned bonus will be made on the basis of the full financial year.

  

	 	(c)	Insurance Coverages and Pension Plans. The Executive shall be entitled to such insurance, pension and all other benefits as are generally made available by the Company to its
executive officers from time to time. 

  

	 	(d)	New Restricted Stock Award. The Company shall grant the Executive restricted shares of the Company’s common stock under The 2004 Rayovac Incentive Plan as follows. On
February 1st 2006, Executive shall be awarded 50,000 shares of the Company’s common stock, shares that will include restrictions prohibiting the sale, transfer, pledge, assignment or other encumbrance of such stock (“Restricted
Shares”), provided, however, that all such restrictions shall lapse on January 31st 2009. Notwithstanding anything else set forth above, (i) restrictions on Restricted Shares shall also lapse on a change in control of the Company (as
defined in the company’s stock plan governing such award) (“Change in Control”) and (ii) any unlapsed shares of Restricted Stock shall be forfeited to the Company in the event the Executive’s employment with the Company
terminates for any reason, other than a without cause termination as noted in paragraph 5(b), prior to a Change in Control. Additional terms and conditions of such restricted stock award shall be set forth in an agreement with such terms and
conditions being substantially similar (other than as set forth above) to the terms and conditions of previous restricted stock award grants to similarly situated Company executives. 

  

	 	(e)	Annual Restricted Stock Awards. Subject to approval by the Compensation Committee of the Board and the Board, on each October 1 during the term of this Agreement
commencing October 1, 2006, the Executive shall be awarded, under The 2004 Rayovac Incentive Plan that number of shares (rounded up to the nearest whole share) of the Company’s common stock with a Fair Market Value equal to One Hundred and
Twenty-Five Percent (125%) of the 

  

 2 

 Base Salary then in effect. Each such award will provide for vesting in four (4) equal tranches on
each December 1st thereafter, beginning the year following the grant date, with (except as otherwise provided
herein or in the applicable plan document) the vesting of Fifty Percent (50%) of each such vesting tranche to be subject to the Executive’s continued employment with the Company as of each applicable December 1st and the remaining Fifty Percent (50%) of each such vesting tranche to be subject to the achievement of performance goals
to be established by the Board from time to time (“Performance-Based Restricted Stock”), provided that One Hundred Percent (100%) of each outstanding vesting tranche shall vest upon a Change in Control. If the required performance
goals are not met in any fiscal year, so that the restrictions on Performance-Based Restricted Stock scheduled to lapse for such year do not so lapse, the restrictions on such Performance-Based Restricted Stock will lapse the December 1 first
following the originally scheduled lapse date. Notwithstanding anything else set forth above, (i) restrictions on such shares shall also lapse on a Change in Control and (ii) any unlapsed shares of restricted stock shall be forfeited to
the Company in the event the Executive’s employment with the Company terminates for any reason prior to a Change in Control. Additional terms and conditions of such restricted stock award shall be set forth in an agreement with such terms and
conditions being substantially similar (other than as set forth above) to the terms and conditions of previous restricted stock award grants to similarly situated Company executives. 
  

	 	(f)	Vacation. The Executive shall be entitled to four (4) weeks vacation each year. 

  

	 	(g)	Other Expenses and Use of Company Aircraft. The Executive shall be entitled to reimbursement of all reasonable and documented expenses actually incurred or paid by the
Executive in the performance of the Executive’s duties under this Agreement, upon presentation of expense statements, vouchers or other supporting information in accordance with Company policy. All expense reimbursements and other perquisites
of the Executive are reviewable periodically by the Compensation Committee of the Board. The Executive shall be eligible to use the Company’s aircraft for personal travel between and among home locations in Wisconsin and Ohio when such aircraft
is not being used for business purposes, subject to the Company’s policy in effect from time to time with respect to personal use of Company aircraft. 

  

	 	(h)	Auto allowance. Subject to the Company’s policy in effect from time to time, during the Executive’s employment, a monthly auto allowance of Fifteen Hundred Dollars
($1500) will be paid subject to normal with-holdings. 

  

	 	(i)	D&O Insurance. The Executive shall be entitled to indemnification from the Company to the maximum extent provided by law, but not for any action, suit, arbitration or
other proceeding (or portion thereof) initiated by the Executive, unless authorized or ratified by 

  

 3 

 the Board. Such indemnification shall be covered by the terms of the Company’s policy of insurance
for directors and officers in effect from time to time (the “D&O Insurance”). Copies of the Company’s charter, by-laws and D&O Insurance will be made available to the Executive upon request. 
  

	 	(j)	Legal Fees. The Company shall pay the Executive’s actual and reasonable legal fees incurred in connection with the preparation of this Agreement.

  

	4.	Termination. 

  

	 	(a)	Termination by the Company with Cause. The Company shall have the right at any time to terminate the Executive’s employment hereunder without prior notice upon the
occurrence of any of the following (any such termination being referred to as a termination for “Cause”): 

  

	 	(i)	the commission by the Executive of any deliberate and premeditated act taken by the Executive in bad faith against the interests of the Company; 

  

	 	(ii)	the Executive has been convicted of, or pleads nolo contendere with respect to, any felony, or of any lesser crime or offense having as its predicate element fraud, dishonesty or
misappropriation of the property of the Company; 

  

	 	(iii)	the current use of illegal drugs, misuse of legal drugs, or intoxication of Executive in the workplace or while performing his duties or responsibilities associated with his
position, the Executive’s failure of a Company-related drug test, or the violation of any Company drug policy; 

  

	 	(iv)	the willful failure or refusal of the Executive to perform his duties as set forth herein or the willful failure or refusal to follow the direction of the CEO, provided such failure
or refusal continues after thirty (30) days of the receipt of notice in writing from the CEO of such failure or refusal, which notice refers to this Section 4(a) and indicates the Company’s intention to terminate the Executive’s
employment hereunder if such failure or refusal is not remedied within such thirty (30) day period; or 

  

	 	(v)	the Executive breaches any of the terms of this Agreement or any other agreement between the Executive and the Company which breach is not cured within thirty (30) days
subsequent to notice from the Company to the Executive of such breach, which notice refers to this Section 4(a) and indicates the Company’s intention to terminate the Executive’s employment hereunder if such breach is not cured within
such thirty (30) day period. 

  

 4 

	 	(b)	Termination by Company for Disability. The Company shall have the right at any time to terminate the Executive’s employment hereunder upon thirty (30) days prior
written notice upon the Executive’s inability to perform his duties hereunder by reason of any mental, physical or other Disability for a period of at least six (6) consecutive months (for purposes hereof, “disability” has the
same meaning as in the Company’s disability policy), if within 30 days after such notice of termination is given, the Executive shall not have returned to the full-time performance of his duties. The Company’s obligations hereunder shall,
subject to the provisions of Section 5(b), also terminate upon the death of the Executive. 

  

	 	(c)	Termination by Company without Cause. The Company shall have the right at any time to terminate the Executive’s employment for any other reason without Cause upon sixty
(60) days prior written notice to the Executive. 

  

	 	(d)	Voluntary Termination by Executive. The Executive shall be entitled to terminate his employment and appointment hereunder upon sixty (60) days prior written notice to
the Company. Any such termination shall be treated as a termination by the Company for “Cause” under Section 5. 

  

	 	(e)	Constructive Termination by the Executive. The Executive shall be entitled to terminate his employment and appointment hereunder, without prior notice, upon the occurrence of
a Constructive Termination. Any such termination shall be treated as a termination by the Company without Cause. For this purpose, a “Constructive Termination” shall mean: 

  

	 	(i)	a reduction in Base Salary (other than as permitted hereby); 

  

	 	(ii)	a reduction in annual Bonus opportunity; 

  

	 	(iii)	a reduction in title; 

  

	 	(iv)	a significant reduction in scope of responsibilities. 

  

	 	(f)	Notice of Termination. Any termination by the Company for Cause shall be communicated by Notice of Termination to the other party hereto given in accordance with
Section 8. For purposes of this Agreement, a “Notice of Termination” means a written notice given prior to the termination which (i) indicates the specific termination provision in this Agreement relied upon, (ii) sets forth
in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated and (iii) if the termination date is other than the date of receipt of such notice,
specifies the termination date of this Agreement (which date shall be not more than fifteen (15) days after the giving of such notice, unless a thirty-day notice is required pursuant to another section of this Agreement). The failure by the
Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not 

  

 5 

 waive any right of the Company hereunder or preclude the Company from asserting such fact or circumstance
in enforcing its rights hereunder. 
  

	5.	Effect of Termination of Employment. 

  

	 	(a)	Termination by the Company with Cause or Voluntarily by the Executive. If the Executive’s employment hereunder is terminated by the Company with Cause or if the
Executive voluntarily terminates his employment hereunder, the Executive’s salary and other benefits specified in Section 3 shall cease at the time of such termination, and the Executive shall not be entitled to any compensation specified
in Section 3 which was not required to be paid prior to such termination; provided, however, that the Executive shall be entitled to continue to participate in the Company’s medical benefit plans to the extent required by law.

  

	 	(b)	Without Cause, Death or Disability. If the Executive’s employment hereunder is terminated as a result of death or Disability or by the Company without Cause and the
Executive executes a separation agreement with a release of claims agreeable to the Company (to the extent that the Executive is physically and mentally capable to execute such an agreement), then the Company shall pay the Executive the amounts and
provide the Executive the benefits as follows: 

  

	 	(i)	The Company shall pay to the Executive as severance, an amount in cash equal to double the sum of (i) the Executive’s Base Salary, and (ii) the annual Bonus (if any)
earned by the Executive pursuant to any annual bonus or incentive plan maintained by the Company in respect of the fiscal year ending immediately prior to the fiscal year in which the termination occurs, such cash amount to be paid to the Executive
ratably monthly in arrears over the 24-month period immediately following such termination. Notwithstanding the foregoing, if required to comply with section 409A of the Internal Revenue Code of 1986, as amended, and any Treasury regulations or
other guidance promulgated thereunder, the Executive will receive the first six (6) months of monthly installment payments required under this Section 5(b)(i) on the six-month anniversary of the date of the Executive’s termination of
employment in a lump-sum payment, and the remaining payments required to be made hereunder shall thereafter be paid in equal consecutive monthly installments for the remainder of such 24 month period. 

  

	 	(ii)	For the greater of (i) the 24-month period immediately following such termination or (ii) the remainder of the Term, the Company shall arrange to provide the Executive and
his dependents the additional benefits specified in Section 3(c) substantially similar to those provided to the Executive and his 

  

 6 

 dependents by the Company immediately prior to the date of termination, at no greater cost to the
Executive or the Company than the cost to the Executive and the Company immediately prior to such date. Benefits otherwise receivable by the Executive pursuant to this Section 5(b)(ii) shall cease immediately upon the discovery by the Company
of the Executive’s breach of the covenants contained in Section 6 or 7 hereof. In addition, benefits otherwise receivable by the Executive pursuant to this Section 5(b)(ii) shall be reduced to the extent benefits of the same type are
received by or made available to the Executive during the 24-month period following the Executive’s termination of employment (and any such benefits received by or made available to the Executive shall be reported to the Company by the
Executive); provided, however, that the Company shall reimburse the Executive for the excess, if any, of the cost of such benefits to the Executive over such cost immediately prior to the date of termination. 
  

	 	(iii)	The Executive’s accrued vacation (determined in accordance with Company policy) at the time of termination shall be paid as soon as reasonably practicable.

  

	 	(iv)	Any payments provided for hereunder shall be paid net of any applicable withholding required under federal, state, or local law and any additional withholding to which the Executive
has agreed. 

  

	 	(v)	If the Executive’s employment with the Company terminates during the Term, the Executive shall not be required to seek other employment or to attempt in any way to reduce any
amounts payable to the Executive by the Company pursuant to this Section 5. 

  

	 	(vi)	Additionally if the Executive’s employment is terminated by the Company without Cause restrictions on Restricted Shares referred to in paragraph 3 (d) shall also lapse
ratably based on complete quarters (three month period) of service. 

  

	6.	Agreement Not to Compete. 

  

	 	(a)	The Executive agrees that during the during his employment and for the one-year period immediately following the termination of his employment for any reason (hereafter, the
“Non-Competition Period”), he will not, directly or indirectly, either separately, jointly or in association with others, as an officer, director, consultant, agent, employee, owner, principal, partner or stockholder of any business,
provide services of the same or similar kind or nature that he provides to the Company to, or have a financial interest in (excepting only the ownership of not more than 5% of the outstanding securities of any class listed on an exchange or the
Nasdaq Stock Market), any competitor of the Company (which means any person or organization that is in the business of or makes money from designing, developing, or selling products or services similar to those products 

  

 7 

 and services developed, designed or sold by the Company). The Executive recognizes, acknowledges and
agrees that his duties and responsibilities as President, North America will be performed throughout the United States and Canada and will result in Executive’s having material contact with the Company’s customers, suppliers, vendors,
and employees throughout the United States and Canada. Accordingly, the Parties acknowledge and agree that the restrictions set forth in this Section 6(a) shall extend to the United States and Canada (hereafter, the “Restricted
Territory”) and that this geographic scope is reasonable based on the geographic scope of Executive’s duties and responsibilities. 
  

	 	(b)	Without limiting the generality of clause (a) above, the Executive further agrees that, during the Non-Competition Period, he will not, within the Restricted Territory,
directly or indirectly, either separately, jointly or in association with others, solicit, divert, take away, or attempt to solicit, divert, or take away, any customer or person to whom the Company has sent a written sales or servicing proposal or
contract in connection with the business of the Company within the immediately preceding two-year period (hereafter, a “Prospective Customer”), for the purpose of or with the intention of selling or providing to such customer or
Prospective Customer any product or service similar to any product or service sold, provided, offered, or under development by the Company during the two-year period immediately preceding the termination of Executive’s employment for any reason
(or during the preceding two years if during Executive’s employment); provided, however, that this restriction shall only apply to customers or Prospective Customers of the Company with whom Executive had contact or about whom the
Executive acquired confidential information by virtue of his employment with the Company at any time during such two-year period. 

  

	 	(c)	The Executive agrees that during the Non-Competition Period, he shall not initiate contact in order to induce, solicit or encourage any person to leave the Company’s employ.
Nothing in this paragraph is meant to prohibit an employee of the Company that is not a party to this Agreement from becoming employed by another organization or person. 

  

	 	(d)	If a court determines that the foregoing restrictions are too broad or otherwise unreasonable under applicable law, including with respect to time or space, the court is hereby
requested and authorized by the parties hereto to revise the foregoing restrictions to include the maximum restrictions allowed under the applicable law. Sections 6(a), 6(b), and 6(c) each are intended to be considered and construed as separate and
independent covenants; any ruling that any one or more of these sections is overbroad or otherwise invalid shall not affect the validity of any of the other sections or any other section of this Agreement.

  

	 	(e)	For purposes of this Section 6 and Section 7, the “Company” refers to the Company and any incorporated or unincorporated affiliates of the Company.

  

 8 

	7.	Secret Processes and Confidential Information. 

  

	 	(a)	The Executive agrees to hold in strict confidence and, except as the Company may authorize or direct, not disclose to any person or use (except in the performance of his services
hereunder) any confidential information or materials received by the Executive from the Company and any confidential information or materials of other parties received by the Executive in connection with the performance of his duties hereunder. For
purposes of this Section 7(a), confidential information or materials shall include, but are not limited to, existing and potential customer information, existing and potential supplier information, product information, design and construction
information, pricing and profitability information, financial information, sales and marketing strategies and techniques and business ideas or practices (hereafter “Confidential Information”). The restriction on the Executive’s use or
disclosure of Confidential Information shall remain in force during the Executive’s employment hereunder and until the earlier of (x) the expiration of a period of two (2) years thereafter or (y) such time as the Confidential
Information is of general knowledge in the industry through no fault of the Executive or any agent of the Executive. The Executive also agrees to return to the Company promptly upon its request any Company information or materials in the
Executive’s possession or under the Executive’s control. This Section 7(a) is not intended to preclude Executive from being gainfully employed by another. Rather, it is intended to prohibit Executive from using the Company’s
confidential information or materials in any subsequent employment or employment undertaken that is not for the benefit of the Company during the identified period. 

  

	 	(b)	The Executive will promptly disclose to the Company and to no other person, firm or entity all inventions, discoveries, improvements, trade secrets, formulas, techniques, processes,
know-how and similar matters, whether or not patentable and whether or not reduced to practice, which are conceived or learned by the Executive during the period of the Executive’s employment with the Company, either alone or with others, which
relate to or result from the actual or anticipated business or research of the Company or which result, to any extent, from the Executive’s use of the Company’s premises or property (collectively called the “Inventions”). The
Executive acknowledges and agrees that all the Inventions shall be the sole property of the Company, and the Executive hereby assigns to the Company all of the Executive’s rights and interests in and to all of the Inventions, it being
acknowledged and agreed by the Executive that all the Inventions are works made for hire. The Company shall be the sole owner of all domestic and foreign rights and interests in the Inventions. The Executive agrees to assist the Company at the
Company’s expense to obtain and from time to time enforce patents and copyrights on the Inventions. 

  

	 	(c)	Upon the request of, and, in any event, upon termination of the Executive’s employment with the Company, the Executive shall 

  

 9 

 promptly deliver to the Company all documents, data, records, notes, drawings, manuals and all other
tangible information in whatever form which pertains to the Company, and the Executive will not retain any such information or any reproduction or excerpt thereof. 
  

	 	(d)	Nothing in this Section 7 diminishes or limits any protection granted by law to trade secrets or relieves the Executive of any duty not to disclose, use or misappropriate any
information that is a trade secret for as long as such information remains a trade secret. 

  

	8.	Notices. All notices or other communications hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered personally, (b) upon
confirmation of receipt when such notice or other communication is sent by facsimile or telex, (c) one day after delivery to an overnight delivery courier, or (d) on the fifth day following the date of deposit in the United States mail if
sent first class, postage prepaid, by registered or certified mail. The addresses for such notices shall be as follows: 

  

	 	(a)	For notices and communications to the Company: 

  
 Spectrum Brands, Inc. 
 Six Concourse Parkway 
 Suite 3300 
 Atlanta, GA 30328 
 Facsimile: (770) 829-6298 
 Attention: James T. Lucke 
  

	 	(b)	For notices and communications to the Executive: 

  
 See the address set forth on the signature page hereto 
  
 Any party hereto may, by notice to the other, change its address for receipt of notices hereunder. 
  

	9.	General. 

  

	 	(a)	Governing Law. This Agreement shall be construed under and governed by the laws of the State of Wisconsin, without reference to its conflicts of law principles.

  

	 	(b)	Amendment; Waiver. This Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms hereof may be waived, only by a written instrument
executed by all of the parties hereto or, in the case of a waiver, by the party waiving compliance. The failure of any party at any time or times to require performance of any provision hereof shall in no manner affect the right at a later time to
enforce the same. No waiver by any party of the breach of any term or covenant contained in this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any
such breach, or a waiver of the breach of any other term or covenant contained in this Agreement. 

  

 10 

	 	(c)	Successors and Assigns. This Agreement shall be binding upon the Executive, without regard to the duration of his employment by the Company or reasons for the cessation of
such employment, and inure to the benefit of his administrators, executors, heirs and assigns, although the obligations of the Executive are personal and may be performed only by him. This Agreement shall also be binding upon and inure to the
benefit of the Company and its subsidiaries, successors and assigns, including any corporation with which or into which the Company or its successors may be merged or which may succeed to their assets or business. 

  

	 	(d)	Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed an original but which together shall constitute one and the same instrument.

  

	 	(e)	Non-exclusivity of Rights. Nothing in this Agreement shall prevent or limit the Executive’s continuing or future participation during his employment hereunder in any
benefit, bonus, incentive or other plan or program provided by the Company or any of its affiliates and for which the Executive may qualify. Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan or
program of the Company or any affiliated company at or subsequent to the date of the Executive’s termination of employment with the Company shall, subject to the terms hereof or any other agreement entered into by the Company and the Executive
on or subsequent to the date hereof, be payable in accordance with such plan or program. 

  

	 	(f)	Mitigation. In no event shall the Executive be obligated to seek other employment by way of mitigation of the amounts payable to the Executive under any of the provisions of
this Agreement. 

  

	 	(g)	Equitable Relief. The Executive expressly agrees that breach of any provision of Sections 6 or 7 of this Agreement would result in irreparable injuries to the Company, that
the remedy at law for any such breach will be inadequate and that upon breach of such provisions, the Company, in addition to all other available remedies, shall be entitled as a matter of right to injunctive relief in any court of competent
jurisdiction without the necessity of proving the actual damage to the Company. 

  

	 	(h)	Severability. Sections 6(a), 6(b), 6(c), 7(a), 7(b) and 9(h) of this Agreement shall be considered separate and independent from each other and from the other sections of
this Agreement and no invalidity of any one of those sections shall affect any other section or provision of this Agreement. However, because it is expressly acknowledged that the pay and benefits provided under this Agreement are provided, at least
in part, as consideration for the obligations imposed upon Executive under Sections 6(a), 6(b), 6(c), 7(a) and 7(b), should Executive challenge those obligations or any court determine that any of the provisions under these Sections is

  

 11 

 unlawful or unenforceable, such that Executive need not honor those provisions, then Executive shall not
receive the pay and benefits, provided for in this Agreement following termination, if otherwise available to Executive, irrespective of the reason for the end of Executive’s employment. 
  

	 	(i)	Entire Agreement. This Agreement and the schedule hereto constitute the entire understanding of the parties hereto with respect to the subject matter hereof and supersede all
prior negotiations, discussions, writings and agreements between them with respect to the subject matter hereof. 

  
 [signature page follows] 
  

 12 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

					
	 	 	Spectrum Brands, Inc.
			
	 	 	By:	 	 /s/ David A. Jones

	 	 	 	 	David A. Jones
	 	 	 	 	Chief Executive Officer
	EXECUTIVE:	 	 	 	 
			
	 /s/ David R. Lumley

	 	 	 	 
	Name: David R Lumley	 	 	 	 
			
	Notice Address:	 	 	 	 
			
	27320 Lake Road	 	 	 	 
	Bay Village, OH 44140	 	 	 	 

  

 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]